Combination of JCXH-211 and anti-PD1 significantly increased the inhibition of EMT6 tumor growth at low but not high dose of JCXH-211 compared to JCXH-211 monotherapy (Fig. 7C–I). The gene discussed is PDCD1; the disease is neoplasm.